Deferred Tax Assets, Operating Loss Carryforwards of Co-Diagnostics, Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
Co-Diagnostics, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $8,552,938, a 112% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$8,552,938	+$4,512,337	+112%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$4,040,601			31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2019	$5,131,100	+$1,289,700	+34%	31 Dec 2019	10-K	25 Mar 2021	2020	FY
Q4 2018	$3,841,400	+$1,304,100	+51%	31 Dec 2018	10-K	30 Mar 2020	2019	FY
Q4 2017	$2,537,300	+$986,400	+64%	31 Dec 2017	10-K	01 Apr 2019	2018	FY
Q4 2016	$1,550,900			31 Dec 2016	10-K	28 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.